PriMera Scientific Medicine and Public Health (ISSN: 2833-5627)

Review Article

Volume 4 Issue 6

Knowledge as Power: Educating the Public on HIV's Past, Present, and Future

Rynee S Wijesinghe and Sampath Wijesinghe*

May 29, 2024

DOI : 10.56831/PSMPH-04-145


In this era, there is a promising path toward halting the HIV pandemic. It underscores the vital importance of spreading accurate HIV information and educating the public. Understanding these facts enables people to grasp the historical, present, and future aspects of HIV, determining the current position and trajectory. While significant progress has been made in combating HIV, there is still much work to be done, emphasizing the need to sustain ongoing efforts. This review aims to raise public awareness of HIV and urges for compassion, insight, and proactive measures. It calls for strength not only in laboratories but also in community engagement and policymaking. As we move forward, let us embrace a renewed sense of optimism and determination. Through collective action, we can relegate HIV to history, turning it from a persistent threat into a defeated adversary. Just a few decades ago, halting HIV seemed improbable. Today, reducing new HIV cases is within reach, exemplified by campaigns like "Let’s Stop HIV Together," which targets a 90% reduction in new cases by 2030. Together, progress has been made, and together, it will continue. Increasing public awareness of HIV and ongoing efforts further strengthens the fight against HIV.


  1. U.S. Department of Health and Human Services. HIV and AIDS: The Basics. National Institutes of Health.
  2. Centers for Disease Control and Prevention. HIV infection is classified as stage 3 (AIDS) if CD4 T-cell count is less than 200 cells/mm3 or if a person has one or more AIDS-defining conditions, regardless of the CD4 T-cell count.
  3. Centers for Disease Control and Prevention. Opportunistic Infections.
  4. Zhang K., et al. “Transmission risk assessment of HIV/AIDS epidemic resulting from sexual transmission in China, 2013-2017”. J Theor Biol 575 (2023): 111635.
  5. Centers for Disease Control and Prevention. HIV Transmission.
  6. Lampe MA., et al. "Achieving elimination of perinatal HIV in the United States". Pediatrics 151.5 (2023): e2022059604.
  7. Alonzo AA and Reynolds NR. “Stigma, HIV and AIDS: An exploration and elaboration of a stigma trajectory”. Soc Sci Med 41.3 (1995): 303-315.
  8. Williams KM., et al. “Defining principles for a choice-based approach to HIV prevention”. Lancet HIV 10.4 (2023): e269-e272.
  9. Mody A., et al. “HIV epidemiology, prevention, treatment, and implementation strategies for public health”. Lancet 403.10425 (2023): 471-492.
  10. Encouraging First-in-Human Results for a Promising HIV Vaccine.
  11. Dieffenbach CW and Fauci AS. “Thirty Years of HIV and AIDS: Future challenges and opportunities”. Ann Intern Med 154.11 (2011): 766-71.
  12. Centers for Disease Control and Prevention. HIV/AIDS.
  13. Bidzha ML, Ngepah N and Greyling T. “The impact of antiretroviral treatment on the relationship between HIV/AIDS and economic growth”. Econ Anal Policy 81 (2024): 368-387.
  14. Centers for Disease Control and Prevention. What Is HIV?.
  15. Centers for Disease Control and Prevention. Clinician Resources.